<DOC>
	<DOCNO>NCT00240747</DOCNO>
	<brief_summary>Open-label , multicenter , multiple-dose , study population pharmacokinetics I.V . Synercid ( 7.5 mg/kg every 8 hour ) 75 pediatric patient . The purpose assess population pharmacokinetics Synercid pediatric patient collect additional safety efficacy data pediatric patient .</brief_summary>
	<brief_title>Open-label , Multiple-dose , Phase III Study Population Pharmacokinetics I.V . Synercid 75 Pediatric Patients</brief_title>
	<detailed_description />
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Gram-Positive Bacterial Infections</mesh_term>
	<mesh_term>Quinupristin-dalfopristin</mesh_term>
	<criteria>Serious , suspect document grampositive infection</criteria>
	<gender>All</gender>
	<minimum_age>27 Weeks</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>May 2012</verification_date>
</DOC>